Mean Platelet Volume (MPV)

Blood

Complete Blood Count (CBC)

Mean platelet volume (MPV) is the average size of your platelets, the cell fragments that drive blood clotting. Larger platelets tend to be younger and more active, so a longevity practice reads MPV as a subtle indicator of platelet activation and of how well the bone marrow is producing them.

What It Measures

Average size of platelets; marker of platelet activation and bone marrow function

Optimal vs. Lab Range

Longevity Optimal

8.0–10.5 fL

Target range for optimal health and longevity based on research.

Standard Lab

7.5–12.0 fL

Population-based reference range from standard labs.

Why It Matters

MPV adds nuance to what the platelet count alone can tell you. Higher MPV reflects larger, more reactive platelets and can accompany platelet activation, diabetes and hyperthyroidism, and has been discussed in the context of cardiovascular risk, since more active platelets may contribute to clotting tendency. Lower MPV tends to appear with bone marrow suppression, aplastic anemia or after chemotherapy, suggesting reduced production of fresh platelets. Interpreted together with the platelet count and RDW, MPV helps distinguish a marrow-production issue from a state of heightened platelet activity.

When Low

Bone marrow suppression, aplastic anemia, chemotherapy effect

When High

Platelet activation, cardiovascular risk, diabetes, hyperthyroidism

How to Optimize

MPV is best influenced by addressing the factors behind platelet activation rather than targeted directly. When it is elevated, general cardiovascular risk management, including blood sugar control, not smoking and an anti-inflammatory dietary pattern, is sensible, and omega-3 intake is sometimes used as an adjunct. A low MPV or an unexplained trend should prompt physician evaluation of bone marrow function and the wider blood count. Targets and treatment are individualized with your physician; this content is educational and not a substitute for medical advice.

Key Interventions & Linked Compounds

Moderate evidence

Key Interventions

Cardiovascular risk management

omega-3

Linked Compounds & Supplements

Omega-3

Aspirin (clinical)

Curated from clinical literature. Individual results vary; consult a qualified clinician before changing a protocol.

Ordering Notes

Specimen

Serum or plasma (venous draw)

Patient prep

No fasting required. Maintain usual diet and medications unless advised.

Recommended cadence

Annual

Reporting unit

Confirm with the performing lab — units vary by region.

Pre-analytic notes

Standardize draw time of day, hydration, and recent exercise. Note any acute illness, supplements, or hormonal therapies on the requisition.

Recommended Follow-Up Actions

1
Confirm the result is reliable
Repeat abnormal values before acting — preferably from the same lab, same time of day, and under consistent prep. Rule out acute illness, recent intense exercise, or medication effects that can shift Mean Platelet Volume (MPV).
2
Compare against optimal, not just lab range
Use the optimal window above as the target. Lab "normal" is built from the general population and often misses early dysfunction.
3
Pair with related markers
Order a complementary panel covering metabolic, inflammatory, and hormonal context to interpret this marker properly.
4
Discuss interventions with a clinician
Use the interpretation guidance above to frame the conversation. Bring trends, not just one datapoint, to your visit.
5
Re-test on a defined cadence
If a change is implemented, re-measure in 8–12 weeks for fast-moving markers, or 3–6 months for slower ones, to confirm response before escalating.